After the permission from the developer of the original scale, the English version was translated into Persian according to the international quality of life assessment (IQOLA) approach. The method is based on forward and backward translation and review of the translation by the experts. For forward translation, the original English version was translated into Persian by two skilled translators. Then a group of experts gave their opinions about the quality of translations and after summing up the opinions, two translators who were fluent in both English and Persian, translated the original scale into Persian. The parts that did not correspond with the English version were changed after discussed with the experts (
18).
It was a non-experimental study including methodological tools, where the construct validity and test-retest reliability of the Persian version of SAFFE were calculated.
The research project was initially approved by the ethics committee of Iran University of Medical Sciences upon obtaining a written consent from all participants.
Sample size was determined according to the following formula:
Equation 1.


α = confidence coefficient; β = power test; r = correlation coefficient.
Samples were selected through a non-probability procedure conveniently through visiting Rasoul Akram hospital, Tehran, Iran. The diagnoses were essentially based on DSM-IV criteria to develop PD in subjects. In this respect, 71 patients were diagnosed with PD given the inclusion and exclusion criteria. Inclusion criteria were as follows:
1, Having at least cognitive level of 23 in the mini-mental status examination (MMSE); 2, no history of diseases such as stroke, dementia, multiple sclerosis and orthopedic problems, impaired balance and fear of falling (information was collected through interviews and those living around the patient); 3, ability to read and write; 4, perfect fluency in Persian.
Exclusion criteria were as follows: Uncooperative patient during assessment.
Patients were evaluated in terms of cognitive level using MMSE, which is a tool to assess cognitive levels (
18). The maximum score on this scale is 30 and the score of 23 and below indicate cognitive pathology (
19).
The level of motor function was calculated through Hoehn and Yahr scale. This measure is widely used as a clinical tool providing classification of motor function in people with PD. This entails a common pattern of motor disorder progression in PD. The scale divides motor function into five levels. In the revised version, levels 1.5 and 2.5 were added (
20).
In the next stage, participants completed the SAFFE questionnaire. Self-reporting scale SAFFE assesses FOF in 11 activities. Activities are scored on a 2-point scale, where 1 implies activity accomplishment and 0 implies failure. Scoring in this scale for FOF covers 3 points, where 3 indicates maximum FOF. Within the limited activity, scoring is on a 2-point scale; 2 implies a person did not perform the activity because of FOF.
The construct validity was evaluated through the Persian version of SAFFE self-report scale using ABC scale where the correlation between them was assessed using the Pearson test. The test-retest reliability was evaluated through intra-class correlation (ICC) and time interval between tests and retests was two weeks. All data were analyzed using SPSS ver. 18. In all tests, P-value less than 0.05 were considered as level of significance.